ReviewInternational journal of molecular sciences2022

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.

Adam J Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.